SBIR/STTR Application Guidance & Resources to Help Commercialize Your Innovation

Thursday, October 1, 2020, 2:00 – 3:30 p.m. ET

Join the Maryland Tech Council (MTC) in collaboration with the National Center for Advancing Translational Sciences (NCATS), the National Institute on Aging (NIA) Office of Small Business Research (OSBR), the Montgomery County Economic Development Corporation (MCEDC) and Rockville Economic Development, Inc. (REDI) on Thursday, October 1, 2020 for a webinar to learn about the Small Business Innovation Research and Small Business Technology Transfer (SBIR/STTR) programs for researchers and entrepreneurs looking to commercialize technologies in translational science and the aging and aging-related disease space.

NCATS offers non-dilutive funding and resources to help small businesses advance and commercialize promising translational biotech and life sciences research technologies. If you are a researcher in these fields and are interested in bringing your innovations to market you may be eligible to apply for the NCATS SBIR and STTR programs.

Register now to join the webinar, SBIR/STTR Application Guidance & Resources to Help Commercialize Your Innovation on Thursday, October 1, 2020, 2:00 – 3:30 p.m. ET

Featured Speakers

Lili M. Portilla, M.P.A.
Director, Office of Strategic Alliances
National Center for Advancing Translational Sciences
National Institutes of Health

Todd Haim, Ph.D.
Chief, Office of Small Business Research
National Institute on Aging
National Institutes of Health

Partners

Martin Rosendale
CEO
Maryland Technology Council

Brad L. Stewart
SVP of Business Development
Montgomery County Economic Development

Cynthia Stewart
CEO
Rockville Economic Development, Inc.

The webinar will feature:

• An overview of the SBIR and STTR programs and benefits of funding
• Key NCATS focus areas to advance clinical research and translational sciences
• Tips for submitting a successful application
• Upcoming opportunities and deadlines
• Other resources and programs, including NCATS’ Therapeutics for Rare and Neglected Diseases (TRND) and Bridging Interventional Development Gaps (BrIDGs) programs

Who Should Attend?
Individuals from the following groups are encouraged to attend:

• Small biotech and/or life sciences technology businesses
• Academic entrepreneurs
• Technology transfer organizations
• Entrepreneurs from women-owned and socially and economically disadvantaged (8a) small businesses.